Life-threatening neurotoxicity following off-label ivermectin use in metastatic breast cancer: a case report (2026)

Peer-Reviewed Study · Saperstein Y; Bou Sanayeh E; Boazak P; Itani H; Moussa E; Gut T · May 2026

Saperstein Y et al., 2026-05: Case report of a 73-year-old woman with metastatic breast cancer who took high-dose ivermectin obtained on her own initiative and developed seizures and respiratory failure requiring intubation, recovering neurologically within 48 hours.

A 73-year-old female with metastatic breast cancer self-administered high doses of ivermectin based on information obtained online. She subsequently developed acute altered mental status, generalized seizures, and respiratory failure.

n/a (PubMed abstract)

Saperstein Y et al., 2026-05: Case report of a 73-year-old woman with metastatic breast cancer who took high-dose ivermectin obtained on her own initiative and developed seizures and respiratory failure requiring intubation, recovering neurologically within 48 hours. Study type: single case report. N: 1. Country: USA (authors' affiliations per article). Dose: 'high doses' self-administered; the abstract does not give an exact milligram amount. Route: self-administered, route not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: n/a. Relevant to the safety and to the dosing claims: it documents harm from unsupervised high-dose use, not from any published protocol. Also filed as IVD-12, IVF-18 (claims C10, C3). Study type: case report.